Hh-i-SPECIFIC SUBSETS OF NATURAL KILLER CELLS Materials and Methods
Animals. All animals were bred and maintained in the mouse colony at the University of Texas Southwestern Medical Center, except for the strains 129/J and B10 .BR which were purchased from The Jackson Laboratory (Bar Harbor, ME).
Production of mAbs. 1 .25 x 106 purified and rIL-2 (Cetus Corp., Emeryville, CA) propagated NK1 .1' cells (1) from C57BL/6 mice (H-2°) were injected into a 129/J mouse (H-2°) intrasplenically (14) . The animal was immunized intrasplenically 8 wk later with 1.5 x 106 purified and rIL-2 propagated NK1 .1' cells from C57BL/6 mice. 3 d after the final injection, the spleen was removed, a cell suspension was made, and the cells were mixed with murine myeloma SP2/0 cells at a ratio of 5:1 . The cells were pelleted at 800 g for 2 min, and the supernatant was discarded. Polyethelene glycol (0.4 ml PEG 1000, British Drug House, Poole, UK) was added, and the cells were resuspended with a pipette for 50 s. The tube was closed and rolled on the counter top for 40 s. 1 ml of hybridoma media (DME, 10% NCTC 109; Irvine Scientific, Santa Ana, CA), 0.15 g/liter oxalacetic acid, 8 .33 mg/liter bovine pancreatic insulin, 13.6 mg/liter hypoxanthine, 3 .9 mg/liter thymidine, 0.22 mg/liter glycine, penicillin/streptomycin) containing 20% FCS was added to the cells . The cell suspension was then added, dropwise, to a flask containing 38 ml of media containing 20% FCS and incubated overnight at 37°C in a 5% 002/95% air atmosphere. The following day, the cells were pelleted at 800 g for 4 min, the supernatant discarded, and the cells were resuspended in HAT (hybridoma media with 0.16 mg/liter aminopterin) containing media. The cells were placed in 96-well round-bottomed plates . The wells were examined for growth after 10 d, and the supernatants from the wells containing hybridomas were tested for their ability to bind to purified C57BL/6 NK1.1' cells but not to C57BL/6 thymocytes by flow cytometry. The hybridomas that produced antibodies that bound to NK cells but not to thymocytes were isolated and cloned twice by limiting dilution for further analysis .
Generation of IL-2-activated NK Cells. Nylon wool nonadherent spleen cells were cultured in 500 U/ml rIL-2 . After 2 d, the nonadherent cells were removed, and the adherent cells washed by rinsing the flask with 5 ml of RPMI 1640 media three times. The nonadherent cells were pelleted and the supernatant was added back to the adherent cells in the flask . These adherent cells were cultured for another 5-7 d. Fresh medium containing rIL-2 was added on the fourth day, if necessary. The cells were harvested and analyzed for cell surface phenotype or used for cell sorting. The cells obtained from this culture were routinely 80-100% NK1 .I' .
Cell Surface Analysis . For staining, rIL-2-activated NK cells or nylon wool nonadherent spleen cells were washed three times in the staining buffer, 1% fraction 5 BSA (Sigma Chemical Co., St. Louis, MO) in PBS . Approximately 5 x 105 cells were used per sample and were stained in 100141 . Primary incubation was with staining buffer alone (negative control) or the appropriate dilution of specific antibody (positive) for 30 min at 4°C followed by two washes in staining buffer. Primary antibodies included : PK136 (anti-NK1 .1), SW3A4, SW5E6, 500A2 (anti T3; provided by Dr. J . Allison, University ofCalifornia at Berkeley), and H02 .2 (anti-Ly-2) . In the secondary incubation, all samples were stained with 50 ill of the appropriate species and isotype-specific secondary antibodies for 30 min at 4°C (all from Jackson Laboratories, West Grove, PA) . After two further washes in staining buffer, the samples were resuspended in 0.4 ml of staining buffer and analyzed on a FACSTAR flow cytometer (Becton Dickinson & Co., Mountain View, CA) .
Cell Sorting and Propagation. Cells were stained as described above and sorted on a FAC-STAR flow cytometer. The sorted cells were propagated in medium containing 500 U/ml rIL-2 and 2-ME (5 x 10-s M) and were plated at 1-2 x 104 cells per well in 96-well, roundbottomed microtiter plates, as previously described (1) .
NK Cell Assay. Spleens were excised from animals, and a cell suspension was made. The red blood cells were lysed by hypotonic shock . Aliquots of 5 x 106 cells were treated with either SW3A4 ascites (1 :50) and baby rabbit complement (BRC), SW5E6 (1 :20) and BRC, or BRC alone. The samples were incubated for 45 min at 37°C. After washing, the cells were assayed for their ability to lyse "Cr labeled YAC-1 tumor cells as previously described (15) .
Treatment of Animals with Antibodies . Animals received a single injection of antibodies intraperitoneally 3 d before lethal irradiation or lung clearance assay, with the exception of anti-asialo GM1 (Wako Chemical Co ., Dallas, TX) which was given intravenously 1 d before lethal irradiation . Antibodies were prepared by ammonium sulfate (50%) precipitation of tissue culture supernatants . 1 .5 mg of SW5E6 or control antibody, 22B5 (antiarsonate ; kindly provided by Dr. Donald Capra, University of Texas Southwestern Medical Center, Dallas, TX), preparations were given to each recipient in the treated groups, and 1 mg of anti-NKI .1 was given to each animal in the anti-NKI .l-treated group.
Stem Cell Growth Assay. All mice were kept in conventional facilities but were given acidified drinking water containing neomycin to prevent sepsis after whole-body irradiation. The animals were exposed to 8.6 Gy of 1s1Cs gamma irradiation (Gamma Cell 40 ; Atomic Energy Ltd., Ottawa, Ontario) . Within 6 h, the mice were infused with BMC in a lateral tail vein. Growth of donor-derived cells was assessed 5 d after the transfer of marrow cells. 60 min after each mouse was given 10' M fluoro-deoxyuridine (0 .15 ml i.p .) to inhibit endogenous deoxythymidylic acid synthesis, each mouse was injected with 0.5 p.Ci 5-iodo-1251-2'-deoxyuridine (IUdR), a thymidine analogue and specific DNA precursor. The spleens were removed 16 h after IUdR injection, and the 1251 radioactivity was measured . The geometric mean (95% confidence limits) splenic uptake (%) values of injected IUdR were calculated for each group (15) . All values have been normalized to the syngeneic control uptake value (100%) .
Lung Clearance Assay. YAC-1 tumor cells (30 x 106) were incubated in 2 ml complete medium with 25,ug/ml 5-fluorodeoxyuridine for 15 min and then 30 p.Ci of 125IUdR was added, and the cells were incubated for an additional 75 min at 37'C in 5% C02 . Cells were washed three times in HBSS and adjusted to 2 x 106/ml. In a volume of 0.5 ml, 106 YAC-1 cells (3-5 x 10 5 cpm) were injected into a lateral tail vein of individual mice . At 3 h after injection the mice were killed, their lungs were removed, and the 1251 radioactivity was measured. Results are expressed as the geometric mean of the percentage recovery of the injected radioactivity.
Lactoperoxidase-catalyzed Radioiodination. Nylon wool nonadherent spleen cells cultured in IL-2, as described above, were harvested and washed in PBS. The cells were labeled with Na 125I (Amersham Corp ., Arlington Heights, IL) as described (16) . Labeled cells were washed in PBS, were lysed in 0.5% NP-40 (Accurate Chemical and Scientific Corp., Hicksville, NY), and were centrifuged at 2,500 g to remove nuclei . 5 % FCS was added to inhibit proteolysis .
Immunoprecipitation and SDS-PAGE. Lysates from radioiodinated cells were incubated with Staphylococcus aureus coated Pansorbin Cells (Calbiochem-Behring Corp ., La Jolla, CA) and rabbit antisera to mouse immunoglobulins (RAMIgs) (Dako Corp ., Santa Barbara, CA) for 30 min at 4°C to remove nonspecific binding components . Aliquots of the precleared cells were incubated with specific antibodies for 2 h at 4°C and Pansorbin cells, coated with RAMIgs, were added for an additional 40 min. The cells were pelleted and washed three times with Tris-buffered saline (pH 8) containing 0.5 % NP-40, 0.2 % sodium deoxycholate, and 0.1 % SDS. The bound proteins were eluted from the cells by boiling them in 217o SDS buffered with Tris (pH 6.8). Eluates were reduced with 10% 2-ME and were analyzed by SDS-PAGE according to the method of Laemmli (17) . Slab gels were dried and were exposed to x-ray film overnight at -70°C.
Statistics. Control samples of 1 :100 dilution of the preparation of IUdR were counted. The purity of the IUdR was 90 %. The formula used to calculate percent IUdR incorporation was: [1251 spleen or lung (cpm)]/[standard (cpm) x purity (0 .9)] . The computed values were converted to loglo numbers to calculate values of mean, SD, and SEM for each group. The geometric means (95% confidence limits) were calculated . Here the arithmetic mean IUdR uptake (%) values of the syngeneic groups (for BMC transplant experiments) were considered 100% growth, and each individual value was calculated as percent growth, which is [experimental/mean syngeneic] x 100. The data are represented on an arithmetic scale and mean t SEM values are shown. There were five to seven animals per group, and parametric, nonparametric, and Student's t test were performed to determine if the mean values were significantly different (p < 0.05) .
Results SW5E6 Antibodies Bind to -40-50% of Murine NK Cells. To determine whether rejection ofHh incompatible BMC was mediated by subsets of NK cells, mAbs against NK cells were produced by immunizing 129/J (H-26) mice with purified NKIV cells from C57BL/6 (H-2e) mice . NK1.1 is a pan NK-specific antigen present on murine NK cells (18) . Several clones were isolated that produced antibodies that bound exclusively to NK cells but not to other lymphocytes (data not shown) . None of the antibodies stained the tumor cell lines EL4 (thymoma), RAW 309.E1.1 (macrophage), P815 (mastocytoma), CTLL-2 (CTL), YAC-1 (thymoma), or 70Z (pre-B cell) (data not shown) . The staining profiles for two of these mAbs .on C57BL/6 NKIV cells are shown in Fig. 1 . SW3A4 is an IgM antibody that binds to all NK cells (Sentman, C. L ., J. Hackett, V. Kumar, and M. Bennett, manuscript in preparation) . SW5E6, on the other hand, is an IgG2a antibody that binds to -50% of purified IL-2-propagated NK1 .1+ cells . In experiments not shown, SW5E6 was found to bind -50% of fresh, sorted splenic NKIV cells as well . 5E6+ cells were purified by cell sorting, and a summary of those experiments is shown in Table I . When sorted cells were cultured in rIL-2 and analyzed for cell surface antigen expression, the 5E6+ cells obtained all expressed 5E6 and NKLI but not T3 (CD3), and their phenotype remained stable after in vitro propagation in IL-2. The 5E6 -cells obtained consisted of 5E6-NK cells and T3' T cells. Although most of the 5E6-cells were T cells, the 5E6 -NK cells proliferated much better in 500 U/ml IL-2 than the T cells and accounted for almost 50% of the final population on day 7 . Thus the 5E6' cells form a distinct and stable subset of murine NK cells . and B10.BR . Based on these data, it is evident that both 5E6+ and 5E6-NK cells are capable of lysing YAC-1 tumor cells . The decrease in NK activity was N50%, as assessed in lytic units, a finding that is consistent with the observation that approximately one-half of NK cells are 5E6+ .
Administration of SW5E6 Antibodies Inhibits Rejection of Hh-Id BALBIc BMC but not Hh-1 e C57BL/6 BMC. We next determined the role of 5E6 + NK cells in the rejection of BMC grafts . The data in Fig. 3 demonstrate that animals given anti-NK1 .1 (PK136), which has been previously shown to remove all NK cell activity in vivo (19), were no longer able to reject H-2d/Hh-Id BALB/c or H-2b/Hh-Ib C57BL/6 BMC. In contrast, treatment of irradiated C57BL/6, (C3H x B6)Fl , B10.BR, and (NZB x B6)Ft recipient mice with SW5E6 antibody prevented rejection of Hh-Id BALB/c BMC (Fig . 3 A) but had no detectable effect upon the ability of B10.A(3R), (C3H x B6)Ft, B10.BR, and (NZB x B6)Fl hosts to reject Hh-l' C57BL/6 BMC (Fig. 3 B) . Since the last three sets of recipients are capable of rejecting both Hh-I" and Hh-Ib BMC grafts, these data force the conclusion that 5E6+ NK cells are necessary for rejection of Hh-ld but not Hh-lb BMC grafts . SW5E6 Does Not Mediate its Effects by Interacting with Stem Cells. It was possible that the SW5E6 antibodies were interacting with Hh-Id BALB/c stem cells, but not the Hh-Ib C57BL/6 stem cells, and in some way protecting them from host NK cells. To test this possibility, BALB/c BMC were treated with SW5E6 and complement in vitro, then transplanted into syngeneic BALB/c hosts and the stem cell activity was measured 5 d later. The results from this experiment are shown in Fig. 4 . Treatment of BMC with SW3A4 (pan-NK) or SW5E6 and complement had no effect on the stem cell activity of BALB/c BMC compared with those treated with complement alone. However, treatment with anti-H-2D" antibodies did reduce stem cell activity. These results indicate that SW5E6 does not interact with stem cells to mediate its effect in vivo.
SW5E6 Treatment Partially Inhibits the Ability ofMice to Lyse YAC-1 Tumor Cells In Viva It was of interest to determine the effect of SW5E6 treatment on in vivo NK activity. The ability of an animal to clear tumor cells from their lungs is considered to be a measurement ofin vivo NK activity (20) . The data is shown in Fig. 5 . When SW5E6 was injected into C57BL/6 (Hh-l'), B10.BR present in similar numbers in strains of mice which do and do not express Hh-Id (data not shown) . These data indicate that both 5E6+ and 5E6-NK cells are capable of lysing YAC-1 tumor cells in vivo.
SW5E6 Treatment Diferentially Inhibits the Ability of Mice to Lyse YAC-1 Tumor Cells In Vivo after Lethal Irradiation . Transplantation of BMC is done in lethally irradiated recipients . The effect of SW5E6 treatment on in vivo NK activity in lethally irradiated mice may be different than that in unirradiated mice . Therefore the effect of SW5E6 on the ability of mice to clear YAC-1 cells from their lungs was measured in animals 1 d after lethal irradiation . The results for mice whose BMC do not express Hh-I' are shown in Fig. 6 A and those for mice whose BMC do express Hh-Id in Fig. 6 B. In all strains there was a partial loss of NK activity in vivo after lethal FIGURE 6 . Effect of SW5E6 on lung clearance activity 1 day after lethal irradiation. Percent 127 1 retention in the lungs 3 h after intravenous infusion of Iz 5IUdR-labeled YAC-1 tumor cells.
Recipient mice were treated with either control (22115) (EI), anti-NKI .l (/, except BALB/c recipients, which were given anti-asialo GMl 2 d before assay), or SW5E6 antibodies (®) 4 d before assay. All mice received 800 rad 1 d before assay. Recipient mice in A are all non-Hh-1°s trains, and recipient mice in B express Hh-1`t. An asterisk indicates that groups are significantly different than the control group treated with 22115. irradiation. The injection of anti-NK1 .1 resulted in significant additional impairment in the ability to clear radiolabeled YAC-1 cells. However, the effects of SW5E6 antibodies differed in mice based upon the expression of Hh-ld. In BALB/c and B10.A(3R) mice, which express Hh-Id, administration of SW5E6 did not impair in vivo NK activity above that which resulted from irradiation alone. In contrast, SW5E6 antibodies had a significant additional effect on lung clearance ability, equivalent to that produced by treatment with anti-NK1 .l antibodies, in irradiated C57BL/6 (Hh-1°), B10.BR (Hh-Ik), and B6D2F1 (Hh-1"ull) mice (which do not express Hh-Id) . 5E6+ NK cells are present both in mice that express Hh-I' and mice that do not express Hh-I' one day after lethal irradiation (data not shown) . Thus it appears that 5E6+ NK cells are not capable of lysing YAC-1 tumor cells after lethal irradiation in mice whose BMC express Hh-Id. The 5E6 Molecule Exists on the Cell Surface as a Homodimer Consisting of Two 54, 000 Mol Wt Subunits. The data in Fig. 7 represent immunoprecipitation of the 5E6 molecule from C57BL/6 (Hh-I') NK cells (Fig. 7 , A and C) or NZB (Hh4d) NK cells (7 B) and separated on SDS-PAGE under reducing (A and B) and nonreducing (C) conditions. The SW5E6 antibodies precipitate a protein ofapparent molecular weight of 54,000 under reducing conditions in all strains tested, including C3H, (C3H x C57BL/6)Ft , and (NZB x C57BL/6)FI mice (data not shown) . Interestingly, under nonreducing conditions, the SW5E6 antibodies immunoprecipitate a molecule of 108-110 x 103 mol wt, suggesting that the 5E6 molecule exists as a homodimer on the cell surface. Discussion NK cells do not express B or T cell receptors, and they have been considered "nonspecific" effector cells. Yet, NK cells do exhibit specificity in the recognition of Hh antigens and it has been difficult to understand how they accomplish this. NK cells have Fc receptors for Ig and could potentially reject BMC grafts using "natural antibodies" via antibody-dependent cellular cytotoxicity (21) . However, mice with severe combined immune deficiency (SLID), which are devoid ofIgs, also specifically reject incompatible BMC, using NK cells (22) . Thus, recognition may be a property of the NK cell itself. The data presented in this report, that reactivity against Hh4d antigens resides in a distinct subpopulation of NK cells, strongly support this notion . Elimination of the 5E6+ subset of NK cells abrogated the ability of inbred mice to resist an Hh-Id incompatible BMC graft, but their ability to resist an Hh-l' incompatible BMC graft was unaffected.
The observation that both 5E6+ and 5E6-NK cells were capable of lysing YAC-1 tumor cells in vitro and in vivo, yet differ in their ability to reject Hh-Id and Hh-16 BMC, suggests that NK cells may use different mechanisms to recognize Hh antigens on BMC and "target structures" on tumor cells.
In addition to reactivity to allogeneic stem cells, NK cells are known to interact with autologous stem cells both in vitro and in vivo (23) . Thomson et al. (24) reported that NK cells are capable of eliminating syngeneic stem cells in vivo after certain viral infections . Therefore it is particularly interesting that Hh-ld mice (BALB/c and B10 .A(3R)), like Hh-l' and Hh-l' mice, possess functional 5E6+ cells that can lyse YAC-1 cells (Figs. 2 and 5 ). Since 5E6+ cells (Hh-I d reactive) exist in Hh-1d mice, some mechanism apparently prevents potentially self-reactive 5E6 + cells from eliminating their own stem cells. This notion is supported by the differential effect of SW5E6 antibodies on in vivo NK activity in mice whose BMC do or do not express Hh-1 1. When injected into mice, SW5E6 antibodies had a minimal effect on the clearance of YAC-1 cells in Hh-ld-type mice, but the effect in animals with other Hh-1 types was much more pronounced (Fig . 5) . This difference was more dramatic after lethal irradiation (Fig. 6, A and B) . Thus it seems that in Hh-Id mice, the function of 5E6+ NK cells is somehow downregulated, by mechanisms that remain to be explored. It will be interesting to investigate the role of 5E6+ NK cells in the regulation of hemopoiesis in Hh-J' mice .
What would be the advantage of having distinct subsets of NK cells for Hh-1 antigens? Distinct subsets of NK cells with different specificities for Hh-1 antigens would allow the reactivity to an individual Hh-1 antigen to be easily altered without affecting other necessary NK cell functions. There is no evidence yet that the 5E6 molecule itself is involved in the recognition of the Hh-Id antigen. Although the 5E6+ subset appears to contain all Hh-Id reactive NK cells, it cannot be concluded that all 5E6+ cells express receptors for Hh-l'. However, if in fact all 5E6 + NK cells do express receptors for Hh-Id, it seems surprising that such a large percentage of NK cells would be devoted to recognition of Hh-Id but not to any of the other four Hh-1 antigens . It is conceivable that receptors for Hh-1 antigens on NK cells are not clonally distributed, i.e., NK cells may express more than one anti-Hh-1 receptor. Allelic exclusion of Ig or TCR genes is necessary for the expression and regulation of B and T cell receptors that must recognize a potentially infinite number of foreign antigens, but NK cells involved in the rejection of BMC grafts only need to recognize five or less Hh-1 antigens . Therefore, the mechanisms for the expression and regulation of NK cell receptors need not be similar to those used by other lymphocytes. The advantage of having NK cells able to recognize more than one Hh-1 antigen would be that a larger amount of the NK cell pool could be responsive to each Hh-1 specificity. Although we have so far only detected subsets of NK cells specific for the Hh-I d antigen, it will be interesting to investigate whether or not other functions attributed to NK cells can be placed into distinct subsets. Summary NK cells demonstrate many immune functions both in vitro and in vivo, including the lysis of tumor or virus-infected cells and the rejection of bone marrow allografts .
However it remains unclear whether or not all NK cells can mediate these various functions or if NK cells exist in functionally distinct subsets . We have developed a new NK-specific mAb, SW5E6, which binds to -50% of murine NK cells. The 5E6 antigen identifies a distinct and stable subset of NK cells and is expressed on about one-half of fresh or rIL-2-activated murine NK cells. Both 5E6 + and 5E6 -NK cells are capable of lysing YAC-1 tumor cells in vitro and in vivo. By treating animals with SW5E6, we demonstrate that the 5E6 + subset is necessary for the rejection of H-2d/Hh-Id but not H-26/Hh-Ib bone marrow cells. Thus NK cells exist as functionally separable subsets in vivo.
